The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

USA: A recent study has highlighted the potential benefits of tirzepatide for overweight and obese adults with type 1 ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their medications elsewhere.

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

US -based pharmaceutical giant Eli Lilly recently launched its weight loss drug Mounjaro in India. Tirzepatide is the generic ...

Over the last few years, there has been an increase in the use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for weight loss ... in 6 months using tirzepatide.

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Mounjaro, a newly launched weight-loss and diabetes drug, is now available in India. Developed by Eli Lilly, it promises more effectiveness than Ozempic and comes at a lower cost. Experts believe it ...